Motivity, a leading provider of clinical SaaS solutions for Applied Behavior Analysis (ABA) providers who treat children with autism, announced a $27 million investment from Five Elms Capital, a leading software investment firm. The funding will enable Motivity to accelerate product innovation, expand its team, and strengthen support for ABA providers worldwide.
"This investment isn't just about scaling; it's about pushing the boundaries of what's possible in ABA technology," said Rex Jakobovits, Founder of Motivity. "Our focus remains the same: delivering intuitive, intelligent solutions that help providers focus on what matters most - improving the lives of children with autism and their families. We couldn't have gotten here without SBIR funding from the National Institute of Mental Health and the support of its business development programs, including the NIH Entrepreneur in Residence consultation and the NIH Company Showcase Program. With Five Elms' partnership, we can accelerate our capacity to innovate and expand our impact."
As Motivity enters its next phase, the company's leadership is evolving to drive future expansion. Founder Rex Jakobovits, PhD, will transition to Chief of Strategy and Innovation, leveraging his expertise to guide the company's long-term vision and technological direction. Joining the team as CEO is Smith Anderson, previously an Operator with Five Elms Capital, who brings extensive experience in scaling technology companies. This leadership transition ensures a blend of innovative vision and operational expertise. Motivity's existing team remains fully intact, providing customers with operational continuity and maintaining the momentum of the platform's ongoing development.
New CEO Anderson agrees, "Motivity remains focused on clinical outcomes. This investment empowers us to expand that mission with enhanced tools, greater scale, and even stronger support. Our dedication to innovation and customer care remains unwavering. We are excited about the opportunities ahead and deeply committed to equipping ABA providers with best-in-class tools to deliver life-changing care."
Motivity will expand its research and development efforts, focusing on AI-driven insights, advanced clinical decision-support tools, and solutions to strengthen caregiver engagement. Additionally, the company will enhance its enterprise capabilities to meet the evolving needs of larger ABA organizations.
"Motivity's team is now well-positioned to grow alongside our customers," said Chief Clinical Officer Emaley McCulloch. "We now have the rocket fuel to expand our reach, refine our solutions, and ensure that more organizations can benefit from the clinical excellence that we bring to the industry."
Comments powered by CComment